NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘central arteriovenous anastomosis’

RSS

January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.

Categories: General
Tags: acute myocardial infarction, biolimus-eluting biodegradable-polymer-coated stent, cardiovascular risk, central arteriovenous anastomosis, dietary sodium, Elecsys Troponin T high-sensitive assay, high-sensitivity cardiac troponin, mortality, myocardial infarction, older patients, uncontrolled hypertension, women, zotarolimus-eluting durable-polymer-coated stent


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Improving Global Air-Quality Indices — The WHO’s New Roadmap June 25, 2026
      Many countries rely on air-quality indices to inform the public and help protect people during short-term increases in air pollution. Their use has important societal and economic implications.
    • Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery June 25, 2026
      In a cluster-randomized trial involving patients having major noncardiac surgery, tranexamic acid reduced the need for red-cell transfusion during hospitalization and was noninferior to placebo for venous thromboembolism within 90 days.
    • When Health Costs No Longer Count — Air Pollution and EPA Rulemaking June 25, 2026
      The EPA has decided to stop considering the monetary value of public health benefits in federal rulemaking related to air pollution. This decision could have profound health consequences.
    • TRACTION for Greater Surgical Use of Tranexamic Acid June 25, 2026
      Every year, many millions of surgical patients worldwide are unnecessarily exposed to a higher-than-necessary risk of blood transfusion because they do not receive a single dose of tranexamic acid just before the surgery. This failing is due not to a lack of high-quality scientific evidence on the overall safety, efficacy,...
    • Catheter Ablation for Persistent Atrial Fibrillation June 25, 2026
      Atrial fibrillation is one of the most common cardiac conditions and is associated with important adverse effects on quality of life, major cardiovascular and neurovascular outcomes, survival, and health care use. Improved outcomes have been seen with pursuit of sinus rhythm,1 and catheter ablation has been more effective...
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |